• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病态肥胖连续患者的肝脏:一项临床、形态学和生化研究。

The liver in consecutive patients with morbid obesity: a clinical, morphological, and biochemical study.

作者信息

Andersen T, Christoffersen P, Gluud C

出版信息

Int J Obes. 1984;8(2):107-15.

PMID:6724792
Abstract

Liver morphology and biochemistry were investigated in 61 morbidly obese subjects selected by defined criteria. Median overweight was 82 per cent (range 61 to 170 per cent), and median duration of overweight was 20 years (range two to 45 years). No patient had more than a moderate alcohol consumption and only one was diabetic. Four biopsies (7 per cent) showed normal liver tissue, while fatty change was the main diagnosis in most cases (85 per cent). Increasing degrees of fatty change was significantly (P less than 0.02) associated with presence of lipogranulomas (found in 54 per cent of the biopsies), focal necroses (found in 28 per cent), slight parenchymal inflammation (found in 33 per cent), and Kupffer cell proliferation (found in 49 per cent). Slight portal inflammation was seen in 23 per cent but portal fibrosis in only 2 per cent of the biopsies. No case of cirrhosis was registered. Patients with moderate or severe fatty change, lipogranulomas , focal necroses or with parenchymal inflammation were significantly more obese than patients without these changes (P less than 0.05). Even in absence of fatty change, obese subjects showed a markedly decreased serum albumin concentration and an elevated serum alkaline phosphatase activity (P less than 0.0001) compared with non-obese controls. Serum lactate dehydrogenase and aspartate aminotransferase were significantly raised only in patients with fatty change. With respect to serum bilirubin and plasma cholesterol concentrations no significant differences were detected between patient subgroups and controls.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

按照明确标准选取了61例病态肥胖受试者,对其肝脏形态和生化指标进行了研究。超重中位数为82%(范围61%至170%),超重持续时间中位数为20年(范围2至45年)。无患者饮酒量超过适度水平,仅1例患有糖尿病。4例活检(7%)显示肝组织正常,而大多数病例(85%)的主要诊断为脂肪变性。脂肪变性程度增加与脂性肉芽肿(在54%的活检中发现)、局灶性坏死(在28%中发现)、轻微实质炎症(在33%中发现)以及库普弗细胞增殖(在49%中发现)显著相关(P<0.02)。23%的活检可见轻微门脉炎症,但仅2%有门脉纤维化。未记录到肝硬化病例。有中度或重度脂肪变性、脂性肉芽肿、局灶性坏死或实质炎症的患者比无这些改变的患者明显更肥胖(P<0.05)。即使没有脂肪变性,与非肥胖对照组相比,肥胖受试者的血清白蛋白浓度也显著降低,血清碱性磷酸酶活性升高(P<0.0001)。仅脂肪变性患者的血清乳酸脱氢酶和天冬氨酸转氨酶显著升高。关于血清胆红素和血浆胆固醇浓度,患者亚组与对照组之间未检测到显著差异。(摘要截断于250字)

相似文献

1
The liver in consecutive patients with morbid obesity: a clinical, morphological, and biochemical study.病态肥胖连续患者的肝脏:一项临床、形态学和生化研究。
Int J Obes. 1984;8(2):107-15.
2
NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).4,4'-硫代双(6-叔丁基间甲酚)(CAS编号:96-69-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(饲料研究)
Natl Toxicol Program Tech Rep Ser. 1994 Dec;435:1-288.
3
Liver morphology in morbid obesity: a literature study.
Int J Obes. 1984;8(2):97-106.
4
Regression of hepatic steatosis in morbidly obese persons after gastric bypass.胃旁路术后病态肥胖者肝脂肪变性的消退
Am J Clin Pathol. 1995 Jul;104(1):23-31. doi: 10.1093/ajcp/104.1.23.
5
Association between elevated serum hepatic enzyme activity and total body fat in obese humans.肥胖人群血清肝酶活性升高与全身脂肪之间的关联。
Ann Clin Lab Sci. 2003 Summer;33(3):257-64.
6
Liver morphology and biochemistry in eight obese patients treated with jejunoileal anastomosis.八例接受空肠回肠吻合术治疗的肥胖患者的肝脏形态学和生物化学
N Engl J Med. 1971 Sep 2;285(10):543-7. doi: 10.1056/NEJM197109022851004.
7
Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies.重度肥胖患者的肝损伤:对1000例肝脏活检的临床 - 生化 - 形态学研究
Obes Surg. 2004 Aug;14(7):952-8. doi: 10.1381/0960892041719644.
8
Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin.病态肥胖与单纯肥胖中的转氨酶活性:空腹胰岛素的预测作用
Nutr Metab Cardiovasc Dis. 2007 Jul;17(6):442-7. doi: 10.1016/j.numecd.2006.02.008. Epub 2006 Jul 11.
9
Fatty liver disease in morbid obesity.病态肥胖中的脂肪肝疾病
Gastroenterol Clin North Am. 1987 Jun;16(2):239-52.
10
Unresectable hepatic metastases from carcinoma of the colon and rectum.无法切除的结肠直肠癌肝转移灶。
Surg Gynecol Obstet. 1985 May;160(5):429-36.

引用本文的文献

1
The association between obesity with serum levels of liver enzymes, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and gamma-glutamyl transferase in adult women.肥胖与成年女性血清肝酶水平、丙氨酸氨基转移酶、天冬氨酸氨基转移酶、碱性磷酸酶和γ-谷氨酰转移酶的关系。
Endocrinol Diabetes Metab. 2022 Nov;5(6):e367. doi: 10.1002/edm2.367. Epub 2022 Aug 30.
2
Interplay of Obesity, Ethanol, and Contaminant Mixture on Clinical Profiles of Cardiovascular and Metabolic Diseases: Evidence from an Animal Study.肥胖、乙醇和污染物混合物对心血管和代谢疾病临床特征的相互作用:来自动物研究的证据。
Cardiovasc Toxicol. 2022 Jun;22(6):558-578. doi: 10.1007/s12012-022-09738-6. Epub 2022 Apr 16.
3
Dietary Patterns and Prevalent NAFLD at Year 25 from the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
饮食模式与冠状动脉风险发展在年轻人(CARDIA)研究中 25 年后的 NAFLD 患病率。
Nutrients. 2022 Feb 18;14(4):854. doi: 10.3390/nu14040854.
4
The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease.胰岛素抵抗、炎症、氧化应激、碱基切除修复与非酒精性脂肪性肝病代谢综合征的相互作用。
Int J Mol Sci. 2021 Oct 15;22(20):11128. doi: 10.3390/ijms222011128.
5
From the origin of NASH to the future of metabolic fatty liver disease.从非酒精性脂肪性肝炎的起源到代谢性脂肪肝病的未来。
Gut. 2021 Feb 25;70(8):1570-9. doi: 10.1136/gutjnl-2020-323202.
6
Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.非酒精性脂肪性肝病:临床特征与发病机制
Gastroenterol Hepatol (N Y). 2006 Apr;2(4):282-291.
7
Prevalence and factors of elevated alanine aminotransferase in central Taiwan - a retrospective study.台湾中部地区丙氨酸氨基转移酶升高的患病率及相关因素——一项回顾性研究
Biomedicine (Taipei). 2016 Jun;6(2):11. doi: 10.7603/s40681-016-0011-7. Epub 2016 May 9.
8
Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese.与健康的病态肥胖者相比,患有糖尿病和血脂异常的病态肥胖者表现出更多的肝脏病变。
BBA Clin. 2016 Jan 8;5:54-65. doi: 10.1016/j.bbacli.2015.12.002. eCollection 2016 Jun.
9
Pancreatic steatosis: Is it related to either obesity or diabetes mellitus?胰腺脂肪变性:与肥胖或糖尿病有关吗?
World J Diabetes. 2014 Aug 15;5(4):415-9. doi: 10.4239/wjd.v5.i4.415.
10
Genome-wide association study on serum alkaline phosphatase levels in a Chinese population.中国人群血清碱性磷酸酶水平的全基因组关联研究。
BMC Genomics. 2013 Oct 5;14:684. doi: 10.1186/1471-2164-14-684.